Delivery Order SPE2DB24D3015-SPE2DB26FFWTY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,156.56 to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with an ultimate completion date of October 14, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on August 27, 2025, with an ultimate completion date of September 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Orgovyx 120 mg tablets (30-count units). This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction under open competition requirements. The ultimate completion date is October 6, 2025, and the product will be delivered to the company's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $1,385.52 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Orgovyx 120 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 20, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,156.56 to AmerisourceBergen Drug Corp for Orgovyx 120 mg tablets (quantity: 30 units) on July 17, 2025, with a completion date of August 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal healthcare vendor that serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Orgovyx 120 mg tablets in a quantity of 30 units, valued at $4,156.56 under a firm fixed-price contract structure. This delivery order is classified as non-set-aside and competitively awarded, with an ultimate completion date of June 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a $1,385.52 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a non-set-aside competitive award with an ultimate completion date of September 25, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed and shipped from the contractor's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-unit packaging) with a firm fixed price structure. The contract is non-competitive and competitively awarded with an ultimate completion date of July 16, 2025. AmerisourceBergen's corporate office, located in Conshohocken, Pennsylvania, serves as both the place of performance and the point of delivery for this pharmaceutical product. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp on June 23, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of July 15, 2025, and represents a non-competitive procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-unit pack) on August 27, 2025, with an ultimate completion date of September 18, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded contract for pharmaceutical procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB26FFWTYDelivery Order
The Defense Logistics Agency awarded a $1,385.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a non-set-aside competitive award with a completion date of November 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The delivery order represents a single transaction under the company's larger indefinite delivery contract vehicle with the DLA. This delivery order is issued under AmerisourceBergen's $999,999,999.00 Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. The IDC enables the contractor to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines across multiple therapeutic domains. The company's demonstrated capability to fulfill such federal medical supply requirements through competitive procurement reflects its established role as a critical vendor for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 10/27/25 |